{
  "issued_date": "2012-10-18", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON195902", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2012/072", 
    "Audience": "Healthcare professionals", 
    "Published": "18 October 2012 at 15:00", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "image/jpeg", 
      "title": "Polyester vascular graft", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/con146531.jpg", 
      "filename": "downloads/18fc9a41bf319880140c04ba19225c3f1eb14f43/con146531.jpg", 
      "original_filename": "con146531.jpg"
    }
  ], 
  "body": "## Device\n\n![ASSET_TAG](#ASSET0)AlboGraft polyester vascular graft.\n\nManufactured by LeMaitre.\n\nAll lots.\n\nThis device is intended to replace damaged or malfunctioning sections of the aorta or more peripheral arteries.\n\n## Problem\n\nIn June 2012 the MHRA lifted the prohibition on the sale of AlboGraft polyester vascular grafts and withdrew MDA/2012/018. \u00a0\n\nHowever, the advice given in [MDA/2012/010MDA/2012/010](http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518) \u2013 that these grafts should be leak tested prior to use \u2013 continues to apply until the end of December 2012.\n\nIn April 2012 the MHRA issued MDA/2012/018 informing users of the Prohibition Notice preventing the manufacturer from selling the AlboGraft in the UK. The MHRA has since carried out a detailed audit of the graft manufacturing facility. \u00a0We were provided with evidence of a number of ongoing changes that the manufacturer was making to the processes to improve control of manufacturing. As a consequence the MHRA has now lifted the Prohibition Notice and permitted sales of the AlboGraft in the UK. Until the end of 2012, however, we are continuing to advise clinicians to undertake the leak test described in [MDA/2012/010](http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518). This is to ensure that products manufactured before and during these improvements do not show any of the previous problems. The MHRA will issue more advice if further significant adverse incidents are reported.\n\n## Action\n\nThis notice updates [MDA/2012/010](http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518).  \n  \n  * Test all affected grafts to assess them for blood leakage prior to implantation. A suitable method involves closing one end of the graft with a haemostat or other clamp and filling it with blood using a syringe with a Tibbs fitting. If any significant degree of blood leakage through the sidewalls of the graft is observed, it should be discarded and an alternative used.  \n  * Ensure you have an appropriate back-up graft in theatre.  \n  * Report any adverse incidents to the MHRA and to the manufacturer.  \n  \n### Action by  \n  \n  * Vascular surgeons.  \n  * Cardiothoracic surgeons.  \n  * Purchasing managers.  \n  \n## Distribution\n\nThis MDA has been sent to:  \n  \n  * NHS trusts in England (chief executives)  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including  \n  \n  * Cardiothoracic departments  \n  * Cardiothoracic surgeons  \n  * Cardiothoracic surgery directors  \n  * Clinical governance leads  \n  * Medical directors  \n  * Nursing executive directors  \n  * Purchasing managers  \n  * Risk managers  \n  * Supplies managers  \n  * Theatre managers  \n  * Theatre nurses  \n  * Theatres  \n  * Vascular surgeons  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Manufacturer Contact\n\nTobias Malcharczik  \nLeMaitre Vascular GmbH  \nOtto-Volger-Str. 5 a/b  \n65843 Sulzbach/Ts.  \nGermany  \nTel:\u00a000 49 6196 659 2315  \nFax:\u00a000 49 6196 527 0702  \nEmail:\u00a0[tmalcharczik@lemaitre.com](mailto:tmalcharczik@lemaitre.com)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\n\n## England\n\nTechnical aspects  \nClare Huntington or Alexander McLaren  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel: 020 3080 7163 / 7292  \nFax: 020 8754 3965  \nEmail:\u00a0 [clare.huntington@mhra.gsi.gov.uk](mailto:clare.huntington@mhra.gsi.gov.uk) or [alexander.mclaren@mhra.gsi.gov.uk](mailto:alexander.mclaren@mhra.gsi.gov.uk)\n\nClinical aspects  \nDr Nicola Lennard  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0020 3080 7126  \nFax:\u00a0020 8754 3965  \nEmail:\u00a0[nicola.lennard@mhra.gsi.gov.uk](mailto:nicola.lennard@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Assembly Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<img src=\"#ASSET0\" alt=\"ASSET_TAG\"><span>AlboGraft polyester vascular graft.</span> \n\n<p><span>Manufactured by LeMaitre.</span></p>\n\n<p><span>All lots.</span></p>\n\n<p>This device is intended to replace damaged or malfunctioning sections of the aorta or more peripheral arteries.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>In June 2012 the MHRA lifted the prohibition on the sale of AlboGraft polyester vascular grafts and withdrew MDA/2012/018. &#160;</span></p>\n\n<p><span>However, the advice given in </span><a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518\">MDA/2012/010<span>MDA/2012/010</span></a><span> &#8211; that these grafts should be leak tested prior to use &#8211; continues to apply until the end of December 2012</span>.</p>\n\n<p>In April 2012 the MHRA issued MDA/2012/018 informing users of the Prohibition Notice preventing the manufacturer from selling the AlboGraft in the UK. The MHRA has since carried out a detailed audit of the graft manufacturing facility. &#160;We were provided with evidence of a number of ongoing changes that the manufacturer was making to the processes to improve control of manufacturing. As a consequence the MHRA has now lifted the Prohibition Notice and permitted sales of the AlboGraft in the UK. Until the end of 2012, however, we are continuing to advise clinicians to undertake the leak test described in <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518\">MDA/2012/010</a>. This is to ensure that products manufactured before and during these improvements do not show any of the previous problems. The MHRA will issue more advice if further significant adverse incidents are reported.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p>This notice updates <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON146518\">MDA/2012/010</a>.</p>\n\n<ul>\n<li>Test all affected grafts to assess them for blood leakage prior to implantation. A suitable method involves closing one end of the graft with a haemostat or other clamp and filling it with blood using a syringe with a Tibbs fitting. If any significant degree of blood leakage through the sidewalls of the graft is observed, it should be discarded and an alternative used.</li>\n\n<li>Ensure you have an appropriate back-up graft in theatre.</li>\n\n<li>Report any adverse incidents to the MHRA and to the manufacturer.</li>\n</ul>\n\n<h3>Action by</h3>\n\n<ul>\n<li>Vascular surgeons.</li>\n\n<li>Cardiothoracic surgeons.</li>\n\n<li>Purchasing managers.</li>\n</ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>NHS trusts in England (chief executives)</li>\n\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including</p>\n\n<ul>\n<li>Cardiothoracic departments</li>\n\n<li>Cardiothoracic surgeons</li>\n\n<li>Cardiothoracic surgery directors</li>\n\n<li>Clinical governance leads</li>\n\n<li>Medical directors</li>\n\n<li>Nursing executive directors</li>\n\n<li>Purchasing managers</li>\n\n<li>Risk managers</li>\n\n<li>Supplies managers</li>\n\n<li>Theatre managers</li>\n\n<li>Theatre nurses</li>\n\n<li>Theatres</li>\n\n<li>Vascular surgeons</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Hospitals in the independent sector</li>\n\n<li>Independent treatment centres</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p><span>Please note:</span> CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p>Tobias Malcharczik<br>\nLeMaitre Vascular GmbH<br>\nOtto-Volger-Str. 5 a/b<br>\n65843 Sulzbach/Ts.<br>\nGermany<br>\nTel:&#160;00 49 6196 659 2315<br>\nFax:&#160;00 49 6196 527 0702<br>\nEmail:&#160;<a href=\"mailto:tmalcharczik@lemaitre.com\">tmalcharczik@lemaitre.com</a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p><span>Technical aspects</span><br>\nClare Huntington or Alexander McLaren<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel: 020 3080 7163 / 7292<br>\nFax: 020 8754 3965<br>\nEmail:&#160; <a href=\"mailto:clare.huntington@mhra.gsi.gov.uk\">clare.huntington@mhra.gsi.gov.uk</a> or <a href=\"mailto:alexander.mclaren@mhra.gsi.gov.uk\">alexander.mclaren@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nDr Nicola Lennard<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;020 3080 7126<br>\nFax:&#160;020 8754 3965<br>\nEmail:&#160;<a href=\"mailto:nicola.lennard@mhra.gsi.gov.uk\">nicola.lennard@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p>Incident Reporting and Investigation Centre<br>\nHealth Facilities Scotland<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)<font class=\"trianglelink\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)</font></a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Assembly Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: AlboGraft polyester vascular graft manufactured by LeMaitre (MDA/2012/072)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": [
    "general-surgery", 
    "theatre-practitioners", 
    "vascular-cardiac-surgery"
  ]
}